Effects of China’s regulatory onslaught felt in Hong Kong as large IPOs fall by the wayside 17 Oct Stock Analysis Published: 11:32am, 17 Oct, 2021 Updated: 11:32am, 17 Oct, 2021 Click here to view the original article.
+ Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight 01 Jan Stock Analysis